Skip to main content
. Author manuscript; available in PMC: 2017 Nov 3.
Published in final edited form as: Transl Cancer Res. 2017 Sep 18;6(Suppl 7):S1253–S1256. doi: 10.21037/tcr.2017.09.37

Table 2.

Key characteristics of IDH-wt and IDH-mut glioblastomas

IDH-wt IDH-mut
Synonym Primary GBM Secondary GBM
Precursor lesion Develops de novo Diffuse astrocytoma, anaplastic astrocytoma
Proportion of glioblastomas ~90% ~10%
Median age at diagnosis ~62 years ~44 years
Male-to-female ratio 1.42:1 1.05:1
Mean length of clinical history 4 months 15 months
Median survival
 Surgery, radiotherapy 9.9 months 24 months
 Surgery, radiotherapy, chemotherapy 15 months 31 months
Location Supratentorial Preferentially frontal
Necrosis Extensive Limited
TERT promoter mutations 72% 26%
TP53 mutations 27% 81%
ATRX mutations Exceptional 71%
EGFR amplification 35% Exceptional
PTEN mutations 24% Exceptional

Table adapted from reference (11).